Expand ABEO Menu
ABEO MENU

ABEO Latest Press Releases

-- October 6, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO Globe Newswire 6:32 PM

-- October 2, 2026 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- September 24, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO PRNewswire 5:46 PM

-- September 22, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO Globe Newswire 6:13 PM

-- September 18, 2026 --

Abeona Therapeutics Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA) Globe Newswire 7:30 AM

-- September 16, 2026 --

Abeona Therapeutics Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN Globe Newswire 7:30 AM

-- September 8, 2026 --

ABEO Investors Have Opportunity to Join Abeona Therapeutics Inc. Fraud Investigation with SBS Law Business Wire 11:26 PM

-- September 2, 2026 --

Abeona Therapeutics Announces Participation in Upcoming Investor Conferences Globe Newswire 7:30 AM

-- September 1, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO Globe Newswire 7:44 PM
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- August 27, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO PRNewswire 4:32 PM

-- August 13, 2026 --

Abeona Therapeutics Reports Second Quarter 2026 Results and Provides Business Update Globe Newswire 7:30 AM

-- August 6, 2026 --

Abeona Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026 Globe Newswire 7:30 AM

-- August 4, 2026 --

CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN Globe Newswire 7:30 AM

-- August 3, 2026 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- July 27, 2026 --

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Abeona Therapeutics Inc. (NASDAQ: ABEO) PRNewswire 8:30 AM

-- July 21, 2026 --

Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN Globe Newswire 7:30 AM

-- July 1, 2026 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- June 1, 2026 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:30 AM

-- May 26, 2026 --

Abeona Therapeutics Announces Participation in Upcoming Investor Conferences Globe Newswire 8:32 AM

-- May 13, 2026 --

Abeona Therapeutics Reports First Quarter 2026 Results and Provides Pipeline Update Globe Newswire 7:30 AM

-- May 11, 2026 --

Abeona Therapeutics Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes